Global Expansion Onyx Scientific is actively expanding its North American presence with the recent appointment of a Business Development Manager in the U.S., indicating an opportunity to promote your services or partnerships to a rapidly growing customer base in North America.

Facility Growth The company has recently invested in expanding its manufacturing capacity with the opening of a new state-of-the-art facility in Sunderland, UK, presenting potential opportunities to collaborate on large-scale production and process development projects.

Industry Focus Operating in the highly specialized pharmaceutical manufacturing sector, Onyx Scientific primarily supports clients through early discovery to commercial API production, suggesting a need for advanced chemistry, API synthesis, and process development solutions.

Reputable Partnerships As a preferred partner for major pharmaceutical firms operating across UK and India, Onyx Scientific's reputation offers a pathway to engage with established industry leaders for advanced CDMO services and custom synthesis projects.

Market Position With revenues estimated between $10 million and $25 million and a focus on small molecule API development, Onyx Scientific presents a growth opportunity for specialized pharmaceutical suppliers and technology providers aiming to serve mid-sized CDMOs.